| Year |
Citation |
Score |
| 2020 |
Fortin JS, Benskey MJ, Lookingland KJ, Patterson JS, Howey EB, Goudreau JL, Schott HC. Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction. Bmc Veterinary Research. 16: 356. PMID 32977825 DOI: 10.1186/s12917-020-02565-3 |
0.634 |
|
| 2017 |
Winner BM, Zhang H, Farthing MM, Karchalla LM, Lookingland KJ, Goudreau JL. Metabolism of Dopamine in Nucleus Accumbens Astrocytes Is Preserved in Aged Mice Exposed to MPTP. Frontiers in Aging Neuroscience. 9: 410. PMID 29311899 DOI: 10.3389/Fnagi.2017.00410 |
0.723 |
|
| 2016 |
Hauser RA, Li R, Pérez A, Ren X, Weintraub D, Elm J, Goudreau JL, Morgan JC, Fang JY, Aminoff MJ, Christine CW, Dhall R, Umeh CC, Boyd JT, Stover N, et al. Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1. Journal of Parkinson's Disease. PMID 27911341 DOI: 10.3233/Jpd-160965 |
0.303 |
|
| 2016 |
Patterson JR, Kim EJ, Goudreau JL, Lookingland KJ. FosB and ΔFosB expression in brain regions containing differentially susceptible dopamine neurons following acute neurotoxicant exposure. Brain Research. PMID 27566062 DOI: 10.1016/J.Brainres.2016.08.030 |
0.713 |
|
| 2016 |
Goudreau JL, Pérez A, Aminoff MJ, Boyd JT, Burau KD, Christine CW, Leehey M, Morgan JC. Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America. Journal of the Neurological Sciences. 366: 74-81. PMID 27288780 DOI: 10.1016/J.Jns.2016.04.021 |
0.314 |
|
| 2016 |
Simkins TJ, Fried D, Parikh K, Galligan JJ, Goudreau JL, Lookingland KJ, Kaplan BL. Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 27287619 DOI: 10.1007/S11481-016-9689-2 |
0.6 |
|
| 2015 |
Hawong HY, Patterson JR, Winner BM, Goudreau JL, Lookingland KJ. Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons. Brain Research. 1622: 240-51. PMID 26141374 DOI: 10.1016/J.Brainres.2015.06.030 |
0.704 |
|
| 2015 |
Tiernan CT, Edwin EA, Hawong HY, Ríos-Cabanillas M, Goudreau JL, Atchison WD, Lookingland KJ. Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase. Toxicological Sciences : An Official Journal of the Society of Toxicology. 144: 347-56. PMID 25601988 DOI: 10.1093/Toxsci/Kfv001 |
0.643 |
|
| 2015 |
Fang JY, Pérez A, Christine CW, Leehey M, Aminoff MJ, Boyd JT, Morgan JC, Dhall R, Nicholas AP, Bodis-Wollner I, Zweig RM, Goudreau JL. Parkinson's disease severity and use of dopaminergic medications. Parkinsonism & Related Disorders. 21: 297-9. PMID 25541182 DOI: 10.1016/J.Parkreldis.2014.10.016 |
0.315 |
|
| 2015 |
Benskey MJ, Manfredsson FP, Lookingland KJ, Goudreau JL. The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure. Neurotoxicology. 46: 1-11. PMID 25447324 DOI: 10.1016/J.Neuro.2014.11.004 |
0.74 |
|
| 2015 |
Credle JJ, George JL, Wills J, Duka V, Shah K, Lee YC, Rodriguez O, Simkins T, Winter M, Moechars D, Steckler T, Goudreau J, Finkelstein DI, Sidhu A. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. Cell Death and Differentiation. 22: 838-51. PMID 25394490 DOI: 10.1038/Cdd.2014.179 |
0.349 |
|
| 2014 |
Simkins T, Crawford RB, Goudreau JL, Lookingland KJ, Kaplan BL. Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 9: 544-57. PMID 24870806 DOI: 10.1007/S11481-014-9549-X |
0.667 |
|
| 2013 |
Benskey M, Lee KY, Parikh K, Lookingland KJ, Goudreau JL. Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein. Neurotoxicology. 37: 144-53. PMID 23643664 DOI: 10.1016/J.Neuro.2013.04.002 |
0.74 |
|
| 2013 |
Tiernan CT, Edwin EA, Goudreau JL, Atchison WD, Lookingland KJ. The role of de novo catecholamine synthesis in mediating methylmercury-induced vesicular dopamine release from rat pheochromocytoma (PC12) cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 133: 125-32. PMID 23425605 DOI: 10.1093/Toxsci/Kft025 |
0.626 |
|
| 2012 |
Simkins TJ, Janis KL, McClure AK, Behrouz B, Pappas SS, Lehner A, Kaminski NE, Goudreau JL, Lookingland KJ, Kaplan BL. Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 533-8. PMID 22639229 DOI: 10.1007/S11481-012-9375-Y |
0.809 |
|
| 2012 |
Benskey M, Behrouz B, Sunryd J, Pappas SS, Baek SH, Huebner M, Lookingland KJ, Goudreau JL. Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression. Neurotoxicology. 33: 321-31. PMID 22342763 DOI: 10.1016/J.Neuro.2012.02.001 |
0.821 |
|
| 2012 |
Ravizza SM, Goudreau J, Delgado MR, Ruiz S. Executive function in Parkinson's disease: contributions of the dorsal frontostriatal pathways to action and motivation. Cognitive, Affective & Behavioral Neuroscience. 12: 193-206. PMID 22006555 DOI: 10.3758/S13415-011-0066-6 |
0.306 |
|
| 2012 |
Benskey M, Behrouz B, Sunryd J, Pappas SS, Baek S, Huebner M, Lookingland KJ, Goudreau JL. Erratum to “Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression” [Neurotoxicology 33 (2012) 321–331] Neurotoxicology. 33: 406. DOI: 10.1016/J.Neuro.2012.04.013 |
0.793 |
|
| 2011 |
Pappas SS, Kennedy T, Goudreau JL, Lookingland KJ. Opioid-mediated regulation of A11 diencephalospinal dopamine neurons: pharmacological evidence of activation by morphine. Neuropharmacology. 61: 614-21. PMID 21605572 DOI: 10.1016/J.Neuropharm.2011.05.002 |
0.674 |
|
| 2011 |
Lehner A, Johnson M, Simkins T, Janis K, Lookingland K, Goudreau J, Rumbeiha W. Liquid chromatographic-electrospray mass spectrometric determination of 1-methyl-4-phenylpyridine (MPP+) in discrete regions of murine brain. Toxicology Mechanisms and Methods. 21: 171-82. PMID 21142843 DOI: 10.3109/15376516.2010.538753 |
0.632 |
|
| 2010 |
Pappas SS, Tiernan CT, Behrouz B, Jordan CL, Breedlove SM, Goudreau JL, Lookingland KJ. Neonatal androgen-dependent sex differences in lumbar spinal cord dopamine concentrations and the number of A11 diencephalospinal dopamine neurons. The Journal of Comparative Neurology. 518: 2423-36. PMID 20503420 DOI: 10.1002/Cne.22340 |
0.778 |
|
| 2009 |
Baek SH, Kim EK, Goudreau JL, Lookingland KJ, Kim SW, Yu SW. Insulin withdrawal-induced cell death in adult hippocampal neural stem cells as a model of autophagic cell death. Autophagy. 5: 277-9. PMID 19158478 DOI: 10.4161/Auto.5.2.7641 |
0.534 |
|
| 2008 |
Janis KL, Brennan RT, Drolet RE, Behrouz B, Kaufman SK, Lookingland KJ, Goudreau JL. Effects of sildenafil on nigrostriatal dopamine neurons in a murine model of Parkinson's disease. Journal of Alzheimer's Disease : Jad. 15: 97-107. PMID 18780970 DOI: 10.3233/Jad-2008-15108 |
0.814 |
|
| 2008 |
Yu SW, Baek SH, Brennan RT, Bradley CJ, Park SK, Lee YS, Jun EJ, Lookingland KJ, Kim EK, Lee H, Goudreau JL, Kim SW. Autophagic death of adult hippocampal neural stem cells following insulin withdrawal. Stem Cells (Dayton, Ohio). 26: 2602-10. PMID 18653772 DOI: 10.1634/Stemcells.2008-0153 |
0.542 |
|
| 2008 |
Pappas SS, Behrouz B, Janis KL, Goudreau JL, Lookingland KJ. Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice. Brain Research. 1214: 1-10. PMID 18462709 DOI: 10.1016/J.Brainres.2008.03.010 |
0.795 |
|
| 2007 |
Behrouz B, Drolet RE, Sayed ZA, Lookingland KJ, Goudreau JL. Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult. Neuroscience. 147: 592-8. PMID 17583437 DOI: 10.1016/J.Neuroscience.2007.05.007 |
0.824 |
|
| 2006 |
Duka T, Rusnak M, Drolet RE, Duka V, Wersinger C, Goudreau JL, Sidhu A. Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2302-12. PMID 17077307 DOI: 10.1096/Fj.06-6092Com |
0.416 |
|
| 2006 |
Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL. Substrate-mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of alpha-synuclein. Journal of Neurochemistry. 96: 950-9. PMID 16412098 DOI: 10.1111/J.1471-4159.2005.03606.X |
0.789 |
|
| 2005 |
Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease. Brain Research. Molecular Brain Research. 134: 155-61. PMID 15790539 DOI: 10.1016/J.Molbrainres.2004.06.029 |
0.467 |
|
| 2004 |
Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Neurotoxicology. 25: 761-9. PMID 15288507 DOI: 10.1016/J.Neuro.2004.05.002 |
0.781 |
|
| 2002 |
Goudreau JL, Maraganore DM, Farrer MJ, Lesnick TG, Singleton AB, Bower JH, Hardy JA, Rocca WA. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 1305-11. PMID 12465073 DOI: 10.1002/Mds.10268 |
0.509 |
|
| 1999 |
Lincoln S, Gwinn-Hardy K, Goudreau J, Chartier-Harlin MC, Baker M, Mouroux V, Richard F, Destée A, Becquet E, Amouyel P, Lynch T, Hardy J, Farrer M. No pathogenic mutations in the persyn gene in Parkinson's disease. Neuroscience Letters. 259: 65-6. PMID 10027558 DOI: 10.1016/S0304-3940(98)00901-X |
0.465 |
|
| 1995 |
Goudreau JL, Falls WM, Lookingland KJ, Moore KE. Periventricular-hypophysial dopaminergic neurons innervate the intermediate but not the neural lobe of the rat pituitary gland. Neuroendocrinology. 62: 147-54. PMID 8584114 DOI: 10.1159/000126999 |
0.617 |
|
| 1994 |
Goudreau JL, Lookingland KJ, Moore KE. 5-Hydroxytryptamine2 receptor-mediated regulation of periventricular-hypophysial dopaminergic neuronal activity and the secretion of alpha-melanocyte-stimulating hormone. The Journal of Pharmacology and Experimental Therapeutics. 268: 175-9. PMID 8301554 |
0.644 |
|
| 1994 |
Goudreau JL, Wagner EJ, Lookingland KJ, Moore KE. gamma-Aminobutyric acid receptor-mediated regulation of periventricular-hypophysial dopaminergic neurons: possible role in mediating stress- and 5-hydroxytryptamine-induced decreases in neuronal activity. The Journal of Pharmacology and Experimental Therapeutics. 271: 1000-6. PMID 7965762 |
0.65 |
|
| 1994 |
Wagner EJ, Goudreau JL, Moore KE, Lookingland KJ. GABAergic regulation of tuberoinfundibular dopaminergic neurons in the male rat. Brain Research. 659: 194-200. PMID 7820661 DOI: 10.1016/0006-8993(94)90878-8 |
0.66 |
|
| 1993 |
Tian Y, Eaton MJ, Goudreau JL, Lookingland KJ, Moore KE. Neurochemical evidence that 5-hydroxytryptaminergic neurons tonically inhibit noradrenergic neurons terminating in the hypothalamus. Brain Research. 607: 215-21. PMID 8481797 DOI: 10.1016/0006-8993(93)91509-Q |
0.698 |
|
| 1993 |
Goudreau JL, Manzanares J, Lookingland KJ, Moore KE. 5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone. The Journal of Pharmacology and Experimental Therapeutics. 265: 303-7. PMID 8386238 |
0.618 |
|
| 1992 |
Goudreau JL, Lindley SE, Lookingland KJ, Moore KE. Evidence that hypothalamic periventricular dopamine neurons innervate the intermediate lobe of the rat pituitary. Neuroendocrinology. 56: 100-5. PMID 1322505 DOI: 10.1159/000126214 |
0.696 |
|
| Show low-probability matches. |